The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.
April 22nd 2024
Eblasakimab shows promising itch relief in dupilumab-experienced atopic dermatitis patients, with significant reductions in symptoms observed.
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Predicting and Preventing Atopic Dermatitis in Children
November 6th 2015Atopic dermatitis, sometimes referred to as baby eczema, affects more than three million infants in the United States every year. While there are no established preventive measures, researchers have been making strides in coming up with effective treatment strategies.
FDA Expands Approval for Ipilimumab to Treat Melanoma
The Food and Drug Administration expanded the approved use of ipilimumab so that it will include a new indication as adjuvant therapy for patients with stage III melanoma. The approval is big news, because it's the first new FDA-approved adjuvant option for late-stage melanoma in two decades.
Unlocking the Combination for Treating Malignant Melanoma
Study results indicate a novel combination of the BRAF inhibitor vemurafenib plus cediranib, an investigational drug that targets the mitogen-activated protein kinase enzymes MEK1 and MEK2, may be effective in treating malignant melanoma.
Kids with Asthma Who Are Allergic to Milk Should Still Receive Immunotherapy
Although asthma increases the risk of anaphylaxis in children with milk allergies and reduces the chance that immunotherapy will prove fully successful, study results show that the majority of patients who undergo immunotherapy for a milk allergy can achieve a protective dose.
T-VEC for Advanced Melanoma Treatment Approved
The US Food and Drug Administration has approved the first-in-class oncolytic immunotherapy talimogene laherparepvec (T-VEC; lmlygic) to treat unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.
Are Older TNF Inhibitors More Effective at Treating Psoriatic Arthritis Than Newer Drugs?
A meta-study of randomized controlled trials indicates that older TNF-inhibitors such as etanercept or infliximab treat psoriatic arthritis more effectively than newer TNF-inhibitors.
Patients Receiving Radiotherapy Have Increased Risk of Complications in Face Lift Procedures
A retrospective review suggests that patients who have cervicofacial rhytidectomy (face lift) after radiotherapy are likely to have increased complication rates over patients who have not had radiotherapy.
Laser and Light Therapy Shows Potential in Treating Hidradenitis Suppurativa
Studies show that laser- and light-based therapies can be effective as adjunct therapy in the treatment of hidradenitis suppurativa. Originally introduced to reduce the size of pores in acne treatment, laser- and light-based therapy is showing potential in other forms of dermatologic treatment.
Study Finds No Link Between Acne Treatment Isotretinoin and Depression Risk
Researchers reported that treatment with isotretinoin is not only associated with significant clinical improvement in patients with moderate to severe acne, but it also did not cause worsening of depression or suicidal thoughts in any of the patients in the study.
Filtered Sunlight is Safe and Noninferior to Phototherapy in Neonatal Hyperbilirubinemia Patients
The use of filtered sunlight is both safe and noninferior to conventional phototherapy for the treatment of neonatal hyperbilirubinemia. This is important because severe neonatal hyperbilirubinemia can lead to fatal complications, and because in some cases, existing guidelines for managing neonatal hyperbilirubinemia explicitly discourage the use of sunlight for the treatment.